Host–microbe interactions in the gut: lessons learned from models of inflammatory bowel diseases
Abstract
The mammalian gut is the richest immune organ in the body and serves as a central location for immune system development, processing, and education. Inflammatory bowel diseases (IBD) provide excellent models for studying both innate and adaptive responses to gut microbes and the host-immune system – microbe interactions in the gut. Microbes are linked to almost all of the known disease-associated genetic polymorphisms in IBD and are critical mediators of environmental effects (through food, hygiene, and infection). Human and animal-based research supports the central role of microbes in IBD pathogenesis at multiple levels. Animal models of IBD only develop in the presence of microbes, and co-housing mice that are genetically susceptible to gut inflammation with normal mice can lead to the development of bowel injury. Recent advances in research technologies, such as deep-sequencing that enables detailed compositional analyses, have revolutionized the study of host–microbe interactions in the gut; however, knowing which bacteria are present in the bowel is likely not sufficient. The function of the microbiota as a community is recognized as a critical factor for gut homeostasis. Animal models of IBD have provided critical insight into basic biology and disease pathogenesis, especially regarding the role of microbes in IBD pathogenesis. Although many of these recent discoveries on host–microbe interactions are not yet applied to patient care, these basic observations will certainly revolutionize patient care in the future. Using such data, we may be able to predict risk of disease, define biological subtypes, establish tools for prevention, and even cure IBD using microbes or their products. A broad spectrum of therapeutic tools spanning from fecal transplantation, probiotics, prebiotics, and microbial products to microbe-tailored diets may supplement current IBD treatments.
Formats available
You can view the full content in the following formats:
REFERENCES
Alipour M., Lou Y., Zimmerman D., Bording-Jorgensen M.W., Sergi C., Liu J.J., and Wine E. A balanced IL-1beta activity is required for host response to Citrobacter rodentium infection PLoS One. 2013 8 e80656
Anderson J.L., Edney R.J., and Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease Aliment. Pharmacol. Ther. 2012 36 503 -516
Arthur J.C., Perez-Chanona E., Muhlbauer M., Tomkovich S., Uronis J.M., Fan T.J., Campbell B.J., Abujamel T., Dogan B., Rogers A.B., Rhodes J.M., Stintzi A., Simpson K.W., Hansen J.J., Keku T.O., Fodor A.A., and Jobin C. Intestinal inflammation targets cancer-inducing activity of the microbiota Science. 2012 338 120 -123
Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., Fernandes G.R., Tap J., Bruls T., Batto J.M., Bertalan M., Borruel N., Casellas F., Fernandez L., Gautier L., Hansen T., Hattori M., Hayashi T., Kleerebezem M., Kurokawa K., Leclerc M., Levenez F., Manichanh C., Nielsen H.B., Nielsen T., Pons N., Poulain J., Qin J., Sicheritz-Ponten T., Tims S., Torrents D., Ugarte E., Zoetendal E.G., Wang J., Guarner F., Pedersen O., de Vos W.M., Brunak S., Doré J., and MetaHIT Consortium Enterotypes of the human gut microbiome Nature. 2011 473 174 -180
Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., Fukuda S., Saito T., Narushima S., Hase K., Kim S., Fritz J.V., Wilmes P., Ueha S., Matsushima K., Ohno H., Olle B., Sakaguchi S., Taniguchi T., Morita H., Hattori M, and Honda K. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota Nature. 2013 500 232 -236
Ayres J.S. Inflammasome-microbiota interplay in host physiologies Cell. Host. Microbe. 2013 14 491 -497
Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases N. Engl. J. Med. 2002 347 911 -920
Backhed F., Fraser C.M., Ringel Y., Sanders M.E., Sartor R.B., Sherman P.M., Versalovic J., Young V., and Finlay B.B. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications Cell. Host. Microbe. 2012 12 611 -622
Baxt L.A., Garza-Mayers A.C., and Goldberg M.B. Bacterial subversion of host innate immune pathways Science. 2013 340 697 -701
Beamish L.A., Osornio-Vargas A.R., and Wine E. Air pollution: an environmental factor contributing to intestinal disease J. Crohns. Colitis. 2011 5 279 -286
Belcheva A., Irrazabal T., Robertson S.J., Streutker C., Maughan H., Rubino S., Moriyama E.H., Copeland J.K., Kumar S., Green B., Geddes K., Pezo R.C., Navarre W.W., Milosevic M., Wilson B.C., Girardin S.E., Wolever T.M., Edelmann W., Guttman D.S., Philpott D.J., and Martin A. Gut microbial metabolism drives transformation of msh2-deficient colon epithelial cells Cell. 2014 158 288 -299
Belkaid Y. and Hand T.W. Role of the microbiota in immunity and inflammation Cell. 2014 157 121 -141
Benjamin J.L., Sumpter R. Jr, Levine B., and Hooper L.V. Intestinal epithelial autophagy is essential for host defense against invasive bacteria Cell. Host. Microbe. 2013 13 723 -734
Brandl K., Plitas G., Mihu C.N., Ubeda C., Jia T., Fleisher M., Schnabl B., DeMatteo R.P., and Pamer E.G. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits Nature. 2008 455 804 -807
Cadwell K., Patel K.K., Maloney N.S., Liu T.C., Ng A.C., Storer C.E., Head R.D., Xavier R., Stappenbeck T.S., and Virgin H.W. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine Cell. 2010 141 1135 -1145
Camilleri M., Madsen K., Spiller R., Greenwood-Van Meerveld B., and Verne G.N. Intestinal barrier function in health and gastrointestinal disease Neurogastroenterol. Motil. 2012 24 503 -512
Castiglione F., Diaferia M., Morace F., Labianca O., Meucci C., Cuomo A., Panarese A., Romano M., Sorrentini I., D'Onofrio C., Caporaso N., and Rispo A. Risk factors for inflammatory bowel diseases according to the “hygiene hypothesis”: a case-control, multi-centre, prospective study in Southern Italy J. Crohns. Colitis. 2012 6 324 -329
Chassaing B., Koren O., Carvalho F.A., Ley R.E., and Gewirtz A.T. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition Gut. 2014 63 1069 -1080
Chen R., Mias G.I., Li-Pook-Than J., Jiang L., Lam H.Y., Chen R., Miriami E., Karczewski K.J., Hariharan M., Dewey F.E., Cheng Y., Clark M.J., Im H., Habegger L., Balasubramanian S., O'Huallachain M., Dudley J.T., Hillenmeyer S., Haraksingh R., Sharon D., Euskirchen G., Lacroute P., Bettinger K., Boyle A.P., Kasowski M., Grubert F., Seki S., Garcia M., Whirl-Carrillo M., Gallardo M., Blasco M.A., Greenberg P.L., Snyder P., Klein T.E., Altman R.B., Butte A.J., Ashley E.A., Gerstein M., Nadeau K.C., Tang H., and Snyder M. Personal omics profiling reveals dynamic molecular and medical phenotypes Cell. 2012 148 1293 -1307
Chiu I.M., Heesters B.A., Ghasemlou N., Von Hehn C.A., Zhao F., Tran J., Wainger B., Strominger A., Muralidharan S., Horswill A.R., Bubeck Wardenburg J., Hwang S.W., Carroll M.C., and Woolf C.J. Bacteria activate sensory neurons that modulate pain and inflammation Nature. 2013 501 52 -57
Chu K.M., Watermeyer G., Shelly L., Janssen J., May T.D., Brink K., Benefeld G., and Li X. Childhood helminth exposure is protective against inflammatory bowel disease: a case control study in South Africa Inflamm. Bowel. Dis. 2013 19 614 -620
Corridoni D., Arseneau K., and Cominelli F. Functional defects in NOD2 signaling in experimental and human Crohn Disease Gut. Microbes. 2014 5 340 -344
Cupi M.L., Sarra M., Marafini I., Franzè E., Ortenzi A., Colantoni A., Sica G., Sileri P., Rosado M.M., Carsetti R., MacDonald T.T., Pallone F., and Monteleone G. Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities J. Immunol. 2014 192 6083 -6091
Czuczman M.A., Fattouh R., van Rijn J.M., Canadien V., Osborne S., Muise A.M., Kuchroo V.K., Higgins D.E., and Brumell J.H. Listeria monocytogenes exploits efferocytosis to promote cell-to-cell spread Nature. 2014 509 230 -234
Dalmasso M., Hill C., and Ross R.P. Exploiting gut bacteriophages for human health Trends. Microbiol. 2014 22 399 -405
D'Argenio V., Precone V., Casaburi G., et al. An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy Am. J. Gastroenterol. 2013 108 851 -852
David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A., Biddinger S.B., Dutton R.J., and Turnbaugh P.J. Diet rapidly and reproducibly alters the human gut microbiome Nature. 2014 505 559 -563
Deuring J.J., Fuhler G.M., Konstantinov S.R., Peppelenbosch M.P., Kuipers E.J., de Haar C., and van der Woude C.J. Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease Gut. 2014 63 1081 -1091
Devkota S., Wang Y., Musch M.W., Leone V., Fehlner-Peach H., Nadimpalli A., Antonopoulos D.A., Jabri B., and Chang E.B. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice Nature. 2012 487 104 -108
D'Haens G.R., Geboes K., Peeters M., Baert F., Penninckx F., and Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology. 1998 114 262 -267
Ding T. and Schloss P.D. Dynamics and associations of microbial community types across the human body Nature. 2014 509 357 -560
Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., and Relman D.A. Diversity of the human intestinal microbial flora Science. 2005 308 1635 -1638
Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., Guiot Y., Derrien M., Muccioli G.G., Delzenne N.M., de Vos W.M., and Cani P.D. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity Proc. Natl. Acad. Sci. USA. 2013 110 9066 -9071
Gareau M.G., Wine E., Reardon C., and Sherman P.M. Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice J. Infect. Dis. 2010 201 81 -91
Garg S.K., Croft A.M., and Bager P. Helminth therapy (worms) for induction of remission in inflammatory bowel disease Cochrane. Database. Syst. Rev. 2014 1 CD009400
Garrett W.S., Lord G.M., Punit S., Lugo-Villarino G., Mazmanian S.K., Ito S., Glickman J.N., and Glimcher L.H. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system Cell. 2007 131 33 -45
Gevers D., Knight R., Petrosino J.F., Huang K., McGuire A.L., Birren B.W., Nelson K.E., White O., Methé B.A., and Huttenhower C. The human microbiome project: a community resource for the healthy human microbiome PLoS Biol. 2012 10 e1001377
Goodrich J.K., Di Rienzi S.C., Poole A.C., Koren O., Walters W.A., Caporaso J.G., Knight R., and Ley R.E. Conducting a microbiome study Cell. 2014 158 250 -262
Gouba N., Raoult D., and Drancourt M. Eukaryote culturomics of the gut reveals new species PLoS One. 2014 9 e106994
Hussey S., Travassos L.H., and Jones N.L. Autophagy as an emerging dimension to adaptive and innate immunity Semin Immunol. 2009 21 233 -41
Huynh H.Q., deBruyn J., Guan L., Diaz H., Li M., Girgis S., Turner J., Fedorak R., and Madsen K. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study Inflamm. Bowel. Dis. 2009 15 760 -768
Jostins L., Ripke S., Weersma R.K., Duerr R.H., McGovern D.P., Hui K.Y., Lee J.C., Schumm L.P., Sharma Y., Anderson C.A., Essers J., Mitrovic M., Ning K., Cleynen I., Theatre E., Spain S.L., Raychaudhuri S., Goyette P., Wei Z., Abraham C., Achkar J.P., Ahmad T., Amininejad L., Ananthakrishnan A.N., Andersen V., Andrews J.M., Baidoo L., Balschun T., Bampton P.A., Bitton A., Boucher G., Brand S., Büning C., Cohain A., Cichon S., D'Amato M., De Jong D., Devaney K.L., Dubinsky M., Edwards C., Ellinghaus D., Ferguson L.R., Franchimont D., Fransen K., Gearry R., Georges M., Gieger C., Glas J., Haritunians T., Hart A., Hawkey C., Hedl M., Hu X., Karlsen T.H., Kupcinskas L., Kugathasan S., Latiano A., Laukens D., Lawrance I.C., Lees C.W., Louis E., Mahy G., Mansfield J., Morgan A.R., Mowat C., Newman W., Palmieri O., Ponsioen C.Y., Potocnik U., Prescott N.J., Regueiro M., Rotter J.I., Russell R.K., Sanderson J.D., Sans M., Satsangi J., Schreiber S., Simms L.A., Sventoraityte J., Targan S.R., Taylor K.D., Tremelling M., Verspaget H.W., De Vos M., Wijmenga C., Wilson D.C., Winkelmann J., Xavier R.J., Zeissig S., Zhang B., Zhang C.K., Zhao H., and International IBD Genetics Consortium (IIBDGC) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature. 2012 491 119 -124
Kao D., Hotte N., Gillevet P., and Madsen K. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile J. Clin. Gastroenterol. 2014 48 625 -628
Khan K.J., Ullman T.A., Ford A.C., Abadir A., Marshall J.K., Talley N.J., and Moayyedi P. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis Am. J. Gastroenterol. 2011 106 661 -673
Klapproth J.M., Sasaki M., Sherman M., Babbin B., Donnenberg M.S., Fernandes P.J., Scaletsky I.C., Kalman D., Nusrat A., and Williams I.R. Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo Infect. Immun. 2005 73 1441 -1451
Knights D., Lassen K.G., and Xavier R.J. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome Gut. 2013 62 1505 -1510
Knutson C.G., Mangerich A., Zeng Y., Raczynski A.R., Liberman R.G., Kang P., Ye W., Prestwich E.G., Lu K., Wishnok J.S., Korzenik J.R., Wogan G.N., Fox J.G., Dedon P.C., and Tannenbaum S.R. Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease Proc. Natl. Acad. Sci. USA. 2013 110 E2332 -E2341
Kostic A.D., Xavier R.J., and Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead Gastroenterology. 2014 146 1489 -1499
Kunde S., Pham A., Bonczyk S., Crumb T., Duba M., Conrad H. Jr, Cloney D., and Kugathasan S. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis J. Pediatr. Gastroenterol. Nutr. 2013 56 597 -601
Lamkanfi M. and Dixit V.M. Mechanisms and functions of inflammasomes Cell. 2014 157 1013 -1022
Larsson E., Tremaroli V., Lee Y.S., Koren O., Nookaew I., Fricker A., Nielsen J., Ley R.E., and Bäckhed F. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88 Gut. 2012 61 1124 -1131
Lassen K.G., Kuballa P., Conway K.L., Patel K.K., Becker C.E., Peloquin J.M., Villablanca E.J., Norman J.M., Liu T.C., Heath R.J., Becker M.L., Fagbami L., Horn H., Mercer J., Yilmaz O.H., Jaffe J.D., Shamji A.F., Bhan A.K., Carr S.A., Daly M.J., Virgin H.W., Schreiber S.L., Stappenbeck T.S., and Xavier R.J. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense Proc. Natl. Acad. Sci. USA. 2014 111 7741 -7746
Levine A., Griffiths A., Markowitz J., Wilson D.C., Turner D., Russell R.K., Fell J., Ruemmele F.M., Walters T., Sherlock M., Dubinsky M., and Hyams J.S. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification Inflamm. Bowel. Dis. 2011 17 1314 -1321
Levine A. and Turner D. Combined azithromycin and metronidazole therapy is effective in inducing remission in pediatric Crohn's disease J. Crohns colitis. 2011 5 222 -226
Levine A. and Wine E. Effects of enteral nutrition on Crohn's disease: clues to the impact of diet on disease pathogenesis Inflamm. Bowel. Dis. 2013 19 1322 -1329
Li J., Jia H., Cai X., Zhong H., Feng Q., Sunagawa S., Arumugam M., Kultima J.R., Prifti E., Nielsen T., Juncker A.S., Manichanh C., Chen B., Zhang W., Levenez F., Wang J., Xu X., Xiao L., Liang S., Zhang D., Zhang Z., Chen W., Zhao H., Al-Aama J.Y., Edris S., Yang H., Wang J., Hansen T., Nielsen H.B., Brunak S., Kristiansen K., Guarner F., Pedersen O., Doré J., Ehrlich S.D., and MetaHIT Consortium An integrated catalog of reference genes in the human gut microbiome Nat. Biotechnol. 2014 32 834 -841
Machiels K., Joossens M., Sabino J., De Preter V., Arijs I., Eeckhaut V., Ballet V., Claes K., Van Immerseel F., Verbeke K., Ferrante M., Verhaegen J., Rutgeerts P., and Vermeire S. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis Gut. 2014 63 1275 -1283
Manichanh C., Borruel N., Casellas F., and Guarner F. The gut microbiota in IBD Nat. Rev. Gastroenterol. Hepatol. 2012 9 599 -608
Markle J.G., Frank D.N., Mortin-Toth S., Robertson C.E., Feazel L.M., Rolle-Kampczyk U., von Bergen M., McCoy K.D., Macpherson A.J., and Danska J.S. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity Science. 2013 339 1084 -1088
Mayer-Barber K.D., Andrade B.B., Oland S.D., Amaral E.P., Barber D.L., Gonzales J., Derrick S.C., Shi R., Kumar N.P., Wei W., Yuan X., Zhang G., Cai Y., Babu S., Catalfamo M., Salazar A.M., Via L.E., Barry C.E. 3rd, and Sher A. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk Nature. 2014 511 99 -103
Michail S., Durbin M., Turner D., Griffiths A.M., Mack D.R., Hyams J., Leleiko N., Kenche H., Stolfi A., and Wine E. Alterations in the gut microbiome of children with severe ulcerative colitis Inflamm. Bowel. Dis. 2012 18 1799 -1808
Muller P.A., Koscso B., Rajani G.M., Stevanovic K., Berres M.L., Hashimoto D., Mortha A., Leboeuf M., Li X.M., Mucida D., Stanley E.R., Dahan S., Margolis K.G., Gershon M.D., Merad M., and Bogunovic M. Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility Cell. 2014 158 300 -313
Neurath M.F. Cytokines in inflammatory bowel disease Nat. Rev. Immunol. 2014 14 329 -342
Ng S.C., Bernstein C.N., Vatn M.H., Lakatos P.L., Loftus E.V. Jr, Tysk C., O'Morain C., Moum B., Colombel J.F., and Epidemiology and Natural History Task Force of the International Organization of Inflammatory Bowel Disease (IOIBD) Geographical variability and environmental risk factors in inflammatory bowel disease Gut. 2013 62 630 -649
Nicholson J.K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., and Pettersson S. Host-gut microbiota metabolic interactions Science. 2012 336 1262 -1267
O'Hara A.M., O'Regan P., Fanning A., O'Mahony C., Macsharry J., Lyons A., Bienenstock J., O'Mahony L., and Shanahan F. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius Immunology. 2006 118 202 -215
Osborne L.C., Monticelli L.A., Nice T.J., Sutherland T.E., Siracusa M.C., Hepworth M.R., Tomov V.T., Kobuley D., Tran S.V., Bittinger K., Bailey A.G., Laughlin A.L., Boucher J.L., Wherry E.J., Bushman F.D., Allen J.E., Virgin H.W., and Artis D. Coinfection. Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation Science. 2014 345 578 -582
Perez-Cobas A.E., Gosalbes M.J., Friedrichs A., Knecht H., Artacho A., Eismann K., Otto W., Rojo D., Bargiela R., von Bergen M., Neulinger S.C., Däumer C., Heinsen F.A., Latorre A., Barbas C., Seifert J., dos Santos V.M., Ott S.J., Ferrer M., and Moya A. Gut. microbiota disturbance during antibiotic therapy: a multi-omic approach Gut. 2013 62 1591 -1601
Perrin S. Preclinical research: make mouse studies work Nature. 2014 507 423 -425
Peterson D.A., Frank D.N., Pace N.R., and Gordon J.I. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases Cell. Host. Microbe. 2008 3 417 -427
Peterson L.W. and Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis Nat. Rev. Immunol. 2014 14 141 -153
Qin J., Li R., Raes J., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., Mende D.R., Li J., Xu J., Li S., Li D., Cao J., Wang B., Liang H., Zheng H., Xie Y., Tap J., Lepage P., Bertalan M., Batto J.M., Hansen T., Le Paslier D., Linneberg A., Nielsen H.B., Pelletier E., Renault P., Sicheritz-Ponten T., Turner K., Zhu H., Yu C., Li S., Jian M., Zhou Y., Li Y., Zhang X., Li S., Qin N., Yang H., Wang J., Brunak S., Doré J., Guarner F., Kristiansen K., Pedersen O., Parkhill J., Weissenbach J., MetaHIT Consortium, Bork P., Ehrlich S.D., and Wang J. A human gut microbial gene catalogue established by metagenomic sequencing Nature. 2010 464 59 -65
Ratsimandresy R.A., Dorfleutner A., and Stehlik C. An update on PYRIN domain-containing pattern recognition receptors: from immunity to pathology Front. Immunol. 2013 4 440
Reese T.A., Wakeman B.S., Choi H.S., Hufford M.M., Huang S.C., Zhang X., Buck M.D., Jezewski A., Kambal A., Liu C.Y., Goel G., Murray P.J., Xavier R.J., Kaplan M.H., Renne R., Speck S.H., Artyomov M.N., Pearce E.J., and Virgin H.W. Coinfection. Helminth infection reactivates latent gamma-herpesvirus via cytokine competition at a viral promoter Science. 2014 345 573 -577
Ridaura V.K., Faith J.J., Rey F.E., Cheng J., Duncan A.E., Kau A.L., Griffin N.W., Lombard V., Henrissat B., Bain J.R., Muehlbauer M.J., Ilkayeva O., Semenkovich C.F., Funai K., Hayashi D.K., Lyle B.J., Martini M.C., Ursell L.K., Clemente J.C., Van Treuren W., Walters W.A., Knight R., Newgard C.B., Heath A.C., and Gordon J.I. Gut microbiota from twins discordant for obesity modulate metabolism in mice Science. 2013 341
Roca F.J. and Ramakrishnan L. TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species Cell. 2013 153 521 -534
Santaolalla R. and Abreu M.T. Innate immunity in the small intestine Curr. Opin. Gastroenterol. 2012 28 124 -129
Santiago A., Panda S., Mengels G., Martinez X., Azpiroz F., Dore J., Guarner F., and Manichanh C. Processing faecal samples: a step forward for standards in microbial community analysis BMC Microbiol. 2014 14 112
Sartor R.B. Microbial influences in inflammatory bowel diseases Gastroenterology. 2008 134 577 -594
Shan M., Gentile M., Yeiser J.R., Walland A.C., Bornstein V.U., Chen K., He B., Cassis L., Bigas A., Cols M., Comerma L., Huang B., Blander J.M., Xiong H., Mayer L., Berin C., Augenlicht L.H., Velcich A., and Cerutti A. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals Science. 2013 342 447 -453
Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel. Dis. 2000 6 107 -115
Shanahan F. The gut microbiota-a clinical perspective on lessons learned Nat. Rev. Gastroenterol. Hepatol. 2012 9 609 -614
Shanahan M.T., Carroll I.M., Grossniklaus E., White A., von Furstenberg R.J., Barner R., Fodor A.A., Henning S.J., Sartor R.B., and Gulati A.S. Mouse Paneth cell antimicrobial function is independent of Nod2 Gut. 2014 63 903 -910
Shaw S.Y., Blanchard J.F., and Bernstein C.N. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease Am. J. Gastroenterol. 2010 105 2687 -2692
Smith M.I., Yatsunenko T., Manary M.J., Trehan I., Mkakosya R., Cheng J., Kau A.L., Rich S.S., Concannon P., Mychaleckyj J.C., Liu J., Houpt E., Li J.V., Holmes E., Nicholson J., Knights D., Ursell L.K., Knight R., and Gordon J.I. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor Science. 2013 339 548 -554
Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly-Y M., Glickman J.N., and Garrett W.S. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis Science. 2013 341 569 -573
Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L.G., Gratadoux J.J., Blugeon S., Bridonneau C., Furet J.P., Corthier G., Grangette C., Vasquez N., Pochart P., Trugnan G., Thomas G., Blottière H.M., Doré J., Marteau P., Seksik P., and Langella P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients Proc. Natl. Acad. Sci. USA. 2008 105 16731 -16736
Tang W.H., Wang Z., Levison B.S., Koeth R.A., Britt E.B., Fu X., Wu Y., and Hazen S.L. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk N. Engl. J. Med. 2013 368 1575 -1584
Tjellstrom B., Hogberg L., Stenhammar L., Magnusson K.E., Midtvedt T., Norin E., and Sundqvist T. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease Scand. J. Gastroenterol. 2012 47 1454 -1459
Tobin D.M., Roca F.J., Oh S.F., McFarland R., Vickery T.W., Ray J.P., Ko D.C., Zou Y., Bang N.D., Chau T.T., Vary J.C., Hawn T.R., Dunstan S.J., Farrar J.J., Thwaites G.E., King M.C., Serhan C.N., and Ramakrishnan L. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections Cell. 2012 148 434 -446
Tremaroli V. and Backhed F. Functional interactions between the gut microbiota and host metabolism Nature. 2012 489 242 -249
Turner D., Levine A., Kolho K.L., Shaoul R., and Ledder O. Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report J. Crohns. Colitis. 2014 2014 in press
Vaishnava S., Behrendt C.L., Ismail A.S., Eckmann L., and Hooper L.V. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface Proc. Natl. Acad. Sci. USA. 2008 105 20858 -20863
Vaishnava S., Yamamoto M., Severson K.M., Ruhn K.A., Yu X., Koren O., Ley R., Wakeland E.K., and Hooper L.V. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine Science. 2011 334 255 -258
VanDussen K.L., Liu T.C., Li D., Towfic F., Modiano N., Winter R., Haritunians T., Taylor K.D., Dhall D., Targan S.R., Xavier R.J., McGovern D.P., and Stappenbeck T.S. Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's disease Gastroenterology. 2014 146 200 -209
van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., Visser C.E., Kuijper E.J., Bartelsman J.F., Tijssen J.G., Speelman P., Dijkgraaf M.G., and Keller J.J. Duodenal infusion of donor feces for recurrent Clostridium difficile New Engl. J. Med. 2013 368 407 -415
Veldhoen M. and Heeney J.L. A helminth-mediated viral awakening Trends. Immunol. 2014 35 452 -453
Wesemann D.R., Portuguese A.J., Meyers R.M., Gallagher M.P., Cluff-Jones K., Magee J.M., Panchakshari R.A., Rodig S.J., Kepler T.B., and Alt F.W. Microbial colonization influences early B-lineage development in the gut lamina propria Nature. 2013 501 112 -115
Whelan K. and Quigley E.M. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease Curr. Opin. Gastroenterol. 2013 29 184 -189
Wine E. Should we be treating the bugs instead of cytokines and T cells? Dig. Dis. 2014 32 403 -409
Wine E., Mack D.R., Hyams J., Otley A.R., Markowitz J., Crandall W.V., Leleiko N., Muise A.M., Griffiths A.M., and Turner D. Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis J. Crohns. Colitis. 2013 7 916 -922
Winter S.E., Winter M.G., Xavier M.N., Thiennimitr P., Poon V., Keestra A.M., Laughlin R.C., Gomez G., Wu J., Lawhon S.D., Popova I.E., Parikh S.J., Adams L.G., Tsolis R.M., Stewart V.J., and Bäumler A.J. Host-derived nitrate boosts growth of E. coli in the inflamed gut Science. 2013 339 708 -711
Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y.Y., Keilbaugh S.A., Bewtra M., Knights D., Walters W.A., Knight R., Sinha R., Gilroy E., Gupta K., Baldassano R., Nessel L., Li H., Bushman F.D., and Lewis J.D. Linking long-term dietary patterns with gut microbial enterotypes Science. 2011 334 105 -108
Wu G.D. and Lewis J.D. Analysis of the human gut microbiome and association with disease Clin. Gastroenterol. Hepatol. 2013 11 774 -777
Zhulina Y., Hahn-Stromberg V., Shamikh A., Peterson C.G., Gustavsson A., Nyhlin N., Wickbom A., Bohr J., Bodin L., Tysk C., Carlson M., and Halfvarson J. Subclinical inflammation with increased neutrophil activity in healthy twin siblings reflect environmental influence in the pathogenesis of inflammatory bowel disease Inflamm. Bowel. Dis. 2013 19 1725 -1731
Information & Authors
Information
Published In
LymphoSign Journal
Volume 1 • Number 2 • December 2014
Pages: 61 - 76
History
Received: 29 July 2014
Accepted: 1 October 2014
Accepted manuscript online: 1 October 2014
Authors
Metrics & Citations
Metrics
Other Metrics
Citations
Cite As
WineEytan. 2014. Host–microbe interactions in the gut: lessons learned from models of inflammatory bowel diseases. LymphoSign Journal.
1(2): 61-76. https://doi.org/10.14785/lpsn-2014-0014
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
There are no citations for this item
View Options
Get Access
Login options
Check if you access through your login credentials or your institution to get full access on this article.
